REG - B.P. Marsh &Partners - New Investment - Amiga Speciality Holdings Limited

B.P. Marsh & PartnersAnnouncement

Wed 14:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250604:nRSD4635La&default-theme=true

RNS Number : 4635L  B.P. Marsh & Partners PLC  04 June 2025

4 June 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Amiga Speciality Holdings Limited ("Amiga")

 

B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor
in early stage financial services businesses, is pleased to announce that it
has subscribed for a 49% shareholding in Amiga, for a nominal consideration.

 

Amiga is a start-up entity, which is looking to build an international
specialty underwriting agency, with a diverse portfolio of speciality products
across key international markets, both organically and via a targeted M&A
strategy.

 

To assist Amiga to achieve their plans, B.P. Marsh has provided a five-year
£10m loan facility, £0.5m of which was drawn down on completion. All
subsequent drawdowns are conditional upon B.P. Marsh's approval.

 

Amiga is headed up by Adam Kembrooke, an industry veteran with over two
decades of experience within the insurance sector. Before founding Amiga, Adam
Kembrooke held several senior positions at Kentro Capital Limited ("Kentro").

 

Adam Kembrooke had a key role in expanding Kentro's presence in the U.S.
market, focusing on speciality insurance lines and strategic acquisitions.

 

Prior to his roles at Kentro, Adam Kembrooke was co-founder of PartnerRe
Wholesale and Senior Vice President at Torus Insurance (UK) Ltd.

 

Adam Kembrooke, Founder & Managing Director of Amiga, commented:-

 

"We are pleased to have the support of B.P. Marsh as we build Amiga into a
leading specialty underwriting platform. With their proven track record in
developing high-performing insurance businesses, we are confident in our
ability to achieve our ambitious business plans."

 

Dan Topping, Chief Investment Officer of the Company, who will be appointed to
the Board of Amiga, commented:-

 

"B.P. Marsh are delighted to be backing Amiga and its experienced leadership
at this early stage. Adam Kembrooke brings deep sector knowledge in the
specialty insurance market and a strategy for growth. We believe Amiga is well
positioned to capitalise on opportunities available within the speciality
market, and we look forward to supporting their journey."

 

 

For further information on B.P. Marsh, its strategy, and current portfolio,
please visit www.bpmarsh.co.uk (http://www.bpmarsh.co.uk/) or
contact:

 

 B.P. Marsh & Partners Plc                           www.bpmarsh.co.uk (http://www.bpmarsh.co.uk/)
 Brian Marsh OBE                                     +44 (0)20 7233 3112

 Nominated Adviser & Joint Corporate Broker

 Panmure Liberum Limited
 Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster  +44 (0)20 7886 2500

 Joint Corporate Broker

 Singer Capital Markets Advisory LLP
 Charles Leigh Pemberton / James Moat / Asha Chotai  +44 (0)20 7496 3000

 Financial PR & Investor Relations
 Tavistock                                           bpmarsh@tavistock.co.uk
 Simon Hudson / Katie Hopkins / Kuba Stawiski        +44 (0)20 7920 3150

 

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFIMJTMTTMBAA